PlainRecalls
FDA Devices Moderate Class II Ongoing

Flo-Thru Intraluminal Shunt. Used in coronary artery or peripheral vascular procedures. Used to shunt blood at the anastomosis to provide a temporary blood-free operative field for suturing while allowing blood to flow distal to the anastomosis.

Reported: May 11, 2022 Initiated: April 1, 2022 #Z-1019-2022

Product Description

Flo-Thru Intraluminal Shunt. Used in coronary artery or peripheral vascular procedures. Used to shunt blood at the anastomosis to provide a temporary blood-free operative field for suturing while allowing blood to flow distal to the anastomosis.

Reason for Recall

There is a potential for foreign matter.

Details

Units Affected
300 devices
Distribution
Distribution in the United States including AL, CA, KY, NY, OR, PA, and TX OUS distribution to Japan, Italy, Netherlands, Switzerland, and United Kingdom
Location
Deerfield, IL

Frequently Asked Questions

What product was recalled?
Flo-Thru Intraluminal Shunt. Used in coronary artery or peripheral vascular procedures. Used to shunt blood at the anastomosis to provide a temporary blood-free operative field for suturing while allowing blood to flow distal to the anastomosis.. Recalled by Baxter Healthcare Corporation. Units affected: 300 devices.
Why was this product recalled?
There is a potential for foreign matter.
Which agency issued this recall?
This recall was issued by the FDA Devices on May 11, 2022. Severity: Moderate. Recall number: Z-1019-2022.